nacubactam: Clinical Trials

2 trials of nacubactam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow nacubactam: new trials by email Literature Review of nacubactam trials Research Report on nacubactam

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants
nacubactam, meropenem - Gram-negative Bacterial Infections
Phase 1CompletedHoffmann-La Roche212017-06-152018-04-23
A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
OP0595, Placebo - Healthy Volunteers, Bacterial Infections
Phase 1CompletedMeiji Seika Pharma Co., Ltd.402014-05-012014-12-12

Conditions studied

Bacterial Infections (1)  ·  Gram-Negative Bacterial Infections (1)

Sponsors

Hoffmann-La Roche (1)  ·  Meiji Seika Pharma Co., Ltd. (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

Mitsuharu Egawa (1)

Results publications

PMID 32041717, PMID 42059802

NIH funding

2016 (1)